Miller Fisher syndrome and polyneuritis cranialis in COVID-19

Синдром Миллера—Фишера и краниальный полиневрит при COVID-19
Julián Benito‐León, Consuelo Gutiérrez-Ortiz, Antonio Méndez-Guerrero, Sara Rodrigo-Rey, Eduardo San Pedro-Murillo, Laura Bermejo‐Guerrero, Ricardo Gordo-Mañas, Fernando de Aragón-Gómez, Eduardo San Pedro Murillo, Ricardo Gordo Mañas, Fernando de Aragón
2020-04-17

COVID-19Miller Fisher syndromeSARS-CoV-2albuminocytologic dissociationpolyneuritis cranialis
OBJECTIVE: To report 2 patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) who presented acutely with Miller Fisher syndrome and polyneuritis cranialis, respectively. METHODS: Patient data were obtained from medical records from the University Hospital "Príncipe de Asturias," Alcalá de Henares, and the University Hospital "12 de Octubre," Madrid, Spain. RESULTS: A 50-year-old man presented with anosmia, ageusia, right internuclear ophthalmoparesis, right fascicular oculomotor palsy, ataxia, areflexia, albuminocytologic dissociation, and positive testing for anti-GD1b-immunoglobulin G antibody. Five days previously, he had developed a cough, malaise, headache, low back pain, and fever. A 39-year-old man presented with ageusia, bilateral abducens palsy, areflexia, and albuminocytologic dissociation. Three days previously, he had developed diarrhea, a low-grade fever, and poor general condition. Oropharyngeal swab test for SARS-CoV-2 by qualitative real-time reverse transcriptase PCR assay was positive in both patients and negative in the CSF. The first patient was treated with IV immunoglobulin and the second with acetaminophen. Two weeks later, both patients made a complete neurologic recovery, except for residual anosmia and ageusia in the first case. CONCLUSIONS: Our 2 cases highlight the rare occurrence of Miller Fisher syndrome and polyneuritis cranialis during the coronavirus disease 2019 (COVID-19) pandemic. These neurologic manifestations may occur because of an aberrant immune response to COVID-19. The full clinical spectrum of neurologic symptoms in patients with COVID-19 remains to be characterized.
1
Both patients achieved complete neurological recovery within two weeks, except for persistent anosmia and ageusia in the Miller Fisher syndrome case.
2
SARS-CoV-2 PCR was positive in oropharyngeal samples but negative in cerebrospinal fluid in both patients, supporting an indirect immune-mediated mechanism.
3
The Miller Fisher syndrome case featured ophthalmoparesis, ataxia, areflexia, albuminocytologic dissociation, and anti-GD1b IgG antibodies.
4
The polyneuritis cranialis case presented with bilateral abducens palsy, areflexia, and albuminocytologic dissociation.
5
Two SARS-CoV-2-infected patients developed acute postinfectious cranial neuropathies: one Miller Fisher syndrome and one polyneuritis cranialis.

Miller Fisher syndrome and polyneuritis cranialis in patients infected with SARS-CoV-2

Acute neurologic manifestations and their possible association with an aberrant immune response to COVID-19

Publication Details
Publication Date
2020-04-17
Journal
Publisher
ISSN
Cited by
816
Access Type
Author Information
Authors
Julián Benito‐León
Consuelo Gutiérrez-Ortiz
Antonio Méndez-Guerrero
Sara Rodrigo-Rey
Eduardo San Pedro-Murillo
Laura Bermejo‐Guerrero
Ricardo Gordo-Mañas
Fernando de Aragón-Gómez
Eduardo San Pedro Murillo
Ricardo Gordo Mañas
Fernando de Aragón
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%